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Abstract
To address the functions of FGFR2 and FGFR3 signaling during mandibular skeletogenesis, we over-
expressed in the developing chick mandible, replication-competent retroviruses carrying truncated
FGFR2c or FGFR3c that function as dominant negative receptors (RCAS-dnFGFR2 and RCAS-
dnFGFR3). Injection of RCAS-dnFGFR3 between HH15−20 led to reduced proliferation, increased
apoptosis, and decreased differentiation of chondroblasts in Meckel's cartilage. These changes
resulted in the formation of a hypoplastic mandibular process and truncated Meckel's cartilage. This
treatment also affected the proliferation and survival of osteoprogenitor cells in osteogenic
condensations, leading to the absence of five mandibular bones on the injected side. Injection of
RCAS-dnFGFR2 between HH15−20 or RCAS-dnFGFR3 at HH26 did not affect the morphogenesis
of Meckel's cartilage but resulted in truncations of the mandibular bones. RCAS-dnFGFR3 affected
the proliferation and survival of the cells within the periosteum and osteoblasts. Together these results
demonstrate that FGFR3 signaling is required for the elongation of Meckel's cartilage and FGFR2
and FGFR3 have roles during intramembranous ossification of mandibular bones.
Introduction
The development of the mandible is a dynamic multi-step process that starts with the formation
of mandibular processes from the first branchial arch. At the time of their formation, the
mandibular processes consist of mesenchyme encased by epithelium derived from ectoderm
and endoderm. The skeletal elements in the mandibular arch are made by cranial neural crest
cells (NCC) (reviewed by Chai and Maxson, 2006; Le Douarin et al., 2004; Santagati and Rijli,
2003). Although NCCs provide species-specific patterning information in the developing
branchial arch skeleton (Schneider and Helms, 2003; Tucker and Lumsden, 2004), the fate and
differentiation of NCCs populating the branchial arches are determined by signaling
interactions with the surrounding tissues, including the endoderm of the foregut and the
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epithelium (reviewed by Chai and Maxson, 2006; Le Douarin et al., 2004; Santagati and Rijli,
2003).
Candidate signaling molecules involved in the morphogenesis of the mandibular processes
include members of the fibroblast growth factor family (FGFs), bone morphogenetic factors
(BMPs), transforming growth factors (TGFs), members of the wingless family (WNTs) and
Sonic hedgehog (Shh) (reviewed by Chai and Maxson, 2006 Francis-West et al., 2003; Mina,
2001; Richman and Lee, 2003; Santagati and Rijli, 2003; Tapadia et al., 2005).
FGFs represent a family of conserved signaling molecules that have been implicated in various
aspects of vertebrate craniofacial development (reviewed by Ellsworth et al., 2002; Nie et al.,
2006; Ornitz, 2005; Ornitz and Marie, 2002). Several FGF and FGF receptors are expressed
in the mandibular epithelium and mesenchyme (reviewed by Nie et al., 2006). The
consequences of perturbations in components of FGF/FGFR signaling have revealed essential
roles of FGF signaling in several aspects of mandibular morphogenesis, including mediating
growth-promoting epithelial-mesenchymal interactions, formation of pharyngeal pouches, and
survival of mandibular mesenchyme (reviewed by Nie et al., 2006).
Loss-of-function analysis of FGF8 provided clear evidence for its involvement in mandibular
morphogenesis. Deletion of Fgf8 from the mandibular epithelium (Trumpp et al., 1999) and
decreased dosage of FGF8 in mice containing hypomorphic alleles of Fgf8 (Abu-Issa et al.,
2002; Frank et al., 2002; Macatee et al., 2003) resulted in formation of a smaller mandible,
extensive apoptosis in mandibular mesenchyme, and loss of skeletal elements in the caudal
region of the mandible including the jaw articulation. Studies in zebrafish provided further
evidence for the roles of FGF signaling in the formation and patterning of pharyngeal pouches
and cartilages in the branchial arches (Crump et al., 2004a; Crump et al., 2004b; David et al.,
2002; Nissen et al., 2003; Trokovic et al., 2003; Walshe and Mason, 2003). Studies in chick
embryos showed roles of FGF signaling in various aspects of mandibular morphogenesis
including the survival of mesenchyme (Wilson and Tucker, 2004), in mediating epithelial-
mesenchymal interactions regulating the outgrowth of the mandibular mesenchyme and
elongation of Meckel's cartilage (Mina et al., 2002; Richman et al., 1997), and in
chondrogenesis of micromass cultures derived from mandibular mesenchyme (Bobick and
Kulyk, 2006; Bobick et al., 2007; Mina et al., 2002). Although these results indicate essential
roles of FGF signaling in mandibular morphogenesis, there remain questions regarding which
of the FGFRs are involved in the skeletogenic differentiation of the NCC-derived mandibular
mesenchyme.
Development of the chick mandibular processes presents an excellent experimental system to
gain further insight into roles of FGF/FGFR signaling in skeletogenesis of NCC-derived
mandibular mesenchyme. In the chick embryo, the mandibular processes are recognizable at
HH15 (E2.5). The formation of Meckel's cartilage starts with the chondrogenic condensations
at around HH25/26 (E5). Later at around HH28 (E6) cells within the chondrogenic
condensations differentiate into chondrocytes and begin synthesis and secretion of cartilage-
specific extracellular matrix proteins, such as aggrecan and type II collagen. Chondrogenic
differentiation in the developing mandible occurs in a caudal to rostral gradient, i.e. it begins
in the caudal region and later extends into the more rostral region (Miyake et al., 1996; Mina
et al., 2007).
The chick mandible contains six bones (angular, supra-angular, articular, splenial, dentary, and
mentomandibular) that are formed in a caudal to rostral gradient by intramembranous
ossification (Mina et al., 2007). The formation of the osteogenic condensations occurs at around
HH31 (E7−7.5) and mineralization of the mandibular bones at HH34 (E8). By HH36 (E10),
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the mandibular processes contain a fully differentiated Meckel's cartilage surrounded by six
mandibular bones (Mina et al., 2007).
The prominent expression of Fgfr2 and Fgfr3 in osteogenic and chondrogenic tissue suggests
essential functions for these receptors during chondrogenesis and osteogenesis in the
mandibular arch. Fgfr2 and Fgfr3 are expressed throughout all phases of chick mandibular
skeletogenesis (Havens et al., 2006; Mina et al., 2002; Wilke et al., 1997). Initially, these
receptors are expressed in mesenchymal condensations giving rise to Meckel's cartilage and
various bones. Later, Fgfr2 and Fgfr3 are expressed in the differentiating Meckel's cartilage
and in the osteoblasts and periosteal tissues of the mandibular bones (Supplemental Fig. 1).
To address the functions of FGFR2 and FGFR3 signaling during mandibular skeletogenesis,
we over-expressed in the developing chick mandible, replication-competent retroviruses
carrying truncated FGFR2c or FGFR3c that function as dominant negative receptors (RCAS-
dnFGFR2 and RCAS-dnFGFR3). Our results demonstrate that FGFR3 signaling is required
for the elongation of Meckel's cartilage, and FGFR2 and FGFR3 have roles during
intramembranous ossification of mandibular bones.
Materials and Methods
Viral constructs and stocks
The dominant-negative FGFR3c construct (RCAS-dnFGFR3) encoding aa 1−401 and
containing a carboxy-terminal c-myc epitope tag was constructed by deletion of sequences past
the transmembrane domain as described (Velonis et al., 2004). A viral construct containing a
kinase deleted form of chick FGFR2c (RCAS-dnFGFR2) encoding aa 1−475 with a carboxy-
terminal hemagglutinin (HA) epitope tag (Ratisoontorn et al., 2003) was kindly provided by
Dr. Hyun-Duck Nah. A viral construct containing the coding sequence of green fluorescent
protein (GFP) (RCAS-GFP) was used as a control (Erceg et al., 2003). Retroviral titers of about
109 pfu/ml were prepared from a chick embryonic fibroblast cell line (DF-1) infected with
various retrovirus vectors as described (Ferrari et al., 1999; Morgan and Fekete, 1996) and
used for all experiments.
Antibodies
AMV-3C2 antibody (Developmental Studies Hybridoma Bank) that recognizes retroviral Gag
protein p19 was used to visualize cells infected with RCAS virus (Potts et al., 1987). Mouse
monoclonal anti-myc (9E10, Sigma) was used to detect expression of myc-tagged dnFGFR3
protein. Mouse monoclonal anti-HA antibodies (HA.11, Covance; F-7, Santa Cruz
Biotechnology) were used to detect expression of HA-tagged dnFGFR2 protein by
immunohistochemistry and Western blot analysis respectively. A rabbit polyclonal anti-
phosphorylated histone 3 (H3-p) antibody (Ser10, Upstate Biotechnologies) was used to
identify mitotic cells (Hendzel et al., 1997).
Western blot analysis
DF-1 cells were infected with 106 cfu/ml of the different viral constructs and cultured for four
days. Cell lysates and Western blot analysis were performed as previously described with minor
modifications (Oliver et al., 1994). Lysates containing equivalent protein (40 μg) were mixed
with SDS-PAGE loading buffer, resolved on 12% SDS-PAGE, and electro-transferred to
Immobilon-P membranes (Millipore Corp). Membranes were incubated for 2 hours with anti-
myc, or anti-HA antibodies at a concentration of 10 μg/ml, and then for 30 min with a 1:10,000
dilution of horseradish-peroxidase linked anti-mouse secondary antibody (Amersham).
Immunoblots were developed using enhanced chemiluminescence (Amersham).
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Mitogenic assay
DF-1 cells were infected for one week with 106 pfu/ml of various viral constructs. The
efficiency of the infection was examined by immunocytochemistry using anti-myc (1:2000
dilution) and anti-HA (1:2500 dilution) antibodies. Infected cultures were then re-plated at a
density of 3 × 105 cells in 35 mm dishes in DMEM medium containing 10% FBS. After 24
hrs, cultures were changed to medium containing 1% FBS and then grown in the presence or
absence of 20 ng/ml FGF2 (R&D Systems) and 10 μg/ml heparin (Sigma). After 48 hrs,
attached cells were harvested with trypsin/EDTA and counted with a Coulter Counter. For each
construct, the percent increase in the number of attached cells in response to FGF2 was
determined relative to that in cells grown in the absence of FGF2. Values represent the mean
± SE from duplicated cultures in at least two independent experiments.
Tissue fixation and processing
Tissue fragments were fixed in freshly prepared 4% paraformaldehyde in PBS at 4°C overnight,
and micromass cultures were fixed in 4% paraformaldehyde for 10 min and scraped from the
culture dishes. All fixed tissues were dehydrated and processed for paraffin embedding. Seven
μm sections were mounted on Probe-On Plus slides and processed for various analyses.
Immunohistochemistry
Immunohistochemistry was performed on paraffin embedded sections. Sections were
quenched in 1% H2O2 and incubated with Target Retrieval Solution (DakoCytomation) for 20
min at 95°C. Slides were incubated with blocking solution and then with primary antibodies
(AMV-3C2: 1/100, 9E10: 1/4000, HA.11: 1/1000, Ser10: 1/1000) overnight at 4°C. Slides
were rinsed and incubated for 30 min at room temperature with a 1:200 dilution of secondary
biotinylated horse-anti-mouse or goat-anti-rabbit antibodies followed by a 30 min incubation
with avidin-biotinylated horseradish peroxidase (Vector Labs). 3−3’-Diaminobenzidine (DAB
Substrate Kit, Vector Labs) was used as the substrate for horseradish peroxidase.
Chicken embryos and microinjections
Fertilized pathogen-free white leghorn chick eggs (SPAFAS; Charles River Laboratories) were
incubated at 37.5°C in a humidified incubator and embryos were staged according to
Hamburger and Hamilton (HH) (Hamburger and Hamilton, 1951). At desired stages of
development (HH15−26, embryonic days E2.5-E5), eggs were windowed and the right side of
the face or right forelimb was exposed by removing the vitelline membrane. Concentrated virus
was thawed and mixed with 4% (v/v) fast green as a tracer dye to visualize the region of
microinjection. Injections were performed using pulled glass capillary pipettes attached to a
Narishinge microinjector. After injection, 1−2 drops of antibiotic/antimycotic were added on
top of the membrane, eggs were sealed and returned to the incubator for various times (Morgan
and Fekete, 1996).
Skeletal whole-mount staining and analysis
Embryos were processed for staining with Alcian blue and alizarin red as previously described
(Wang et al., 1998).
In situ hybridization to whole-mounts and sections
Whole-mount hybridization using digoxigenin-labeled RNA probes and hybridization to tissue
sections using 32P-labeled antisense RNA probes were performed as previously described
(Mina et al., 2002). The cDNAs for this study included Fgfr2 and Fgfr3 (Mina et al., 2002),
Sox9 (Healy et al., 1999), dHand (Srivastava et al., 1995), Barx1 (Barlow et al., 1999), Dlx5
(Ferrari et al., 1999), Msx1 (Mina et al., 1995), PTH-1R (Vortkamp et al., 1996), Runx2
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(Stricker et al., 2002), Osteocalcin (Neugebauer et al., 1995) and aggrecan core protein (Mina
et al., 2007). Individuals who kindly provided these cDNAs include Drs. C. Healy (Sox9), D.
Srivastava (dHand), P. Francis-West (Barx1), R. Kosher (Dlx5), C. Tabin (PTH-1R), S. Sticker
(Runx2), L. Gerstenfeld (Osteocalcin), and M. Tanzer (aggrecan). Following in situ
hybridization, the sections were stained with hematoxylin or toluidine blue and mounted with
Permount. Using Adobe Photoshop 7.0 software, the silver grains in the dark-field image were
selected, colored red, and then superimposed onto the bright-field images.
Cell proliferation and apoptosis assays
For analysis of cell proliferation, mandibles were fixed two to six days after injection and
subjected to immunohistochemistry with an H3-p antibody as described above. An in Situ Cell
Death Detection Kit (Roche) was used to detect apoptotic cells in sections adjacent to those
used for analysis of cell proliferation in each mandible. For quantitative analysis, equivalently
defined areas on the injected and uninjected sides were outlined and measured using ImageJ
software. Defined areas after injection between HH17−20, included the entire area of the
mandibular mesenchyme at day two (8−12 sections), the area of newly formed Meckel's
cartilage (defined by Alcian blue staining and morphological criteria) at day three (6 sections),
different regions of differentiated Meckel's cartilage at day four (rostral, middle and caudal
third) (10−12 longitudinal and 13−15 cross sections), and the condensation for the supra-
angular bone at day four as defined by proximity to the caudal region of Meckel's cartilage (8
−17 sections). The cell proliferation and apoptosis in differentiated angular bone was measured
in 8−13 sections six days after injection at HH26. In each defined area, H3-p positive and
TUNEL-positive cells were individually counted using ImageJ. Values for cell proliferation
and apoptosis represent the mean ± SE of positively stained cells/mm2 that were determined
from 6−17 sections (described above) from at least four different embryos at each time point.
Micromass cultures and analyses
Micromass cultures were prepared from the mandibular mesenchyme of HH23 pathogen-free
chick embryos as previously described (Mina et al., 1991). Infection of micromass cultures
was carried out as previously described (Lizarraga et al., 2002) with some modifications.
Briefly, before plating, dissociated cells (1.5 × 107 cells/ml) were incubated in medium with
10% fetal calf serum containing 2.5 × 109 pfu/ml of various viruses at 37°C for 2 hours. The
cells were then plated as 20 μl spots in the center of 4 well plates. After 2 hours, media
containing a 60:40 ratio of F12:DMEM, 2% fetal calf serum, 2 mM glutamine, 200 μg/ml
ascorbic acid, 100 units/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml fungizone and
108 pfu/ml of viruses was added. The accumulation of cartilage matrix was monitored
histochemically by staining with Alcian blue (Mina et al., 1991), and was quantified after
extraction of Alcian blue spectrophotometrically using an ELISA reader with a 630nm filter
(Hassell and Horigan, 1982; Meyer et al., 2001). Histochemical staining for Peanut agglutinin
(PNA), was performed as previously described (Gehris et al., 1997) with 100 μg/ml peroxidase-
conjugated PNA (Sigma) and a DAB substrate kit (Vector Laboratories). The areas of cultures
stained with PNA and Alcian blue were quantified using the Color Range and Histogram
commands in Adobe Photoshop (version 7.0) on images acquired under identical exposure and
lighting conditions. To determine the ratio of PNA to Alcian blue staining in each culture, PNA
stained cultures were restained with Alcian blue. Values for all micromass experiments
represent mean ± SE determined from triplicate cultures in at least two independent
experiments.
Statistical analysis
Unpaired, two-tailed t tests were performed to determine statistically significance differences
and p < 0.01 was considered statistically significant.
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Results
Characterization of dominant negative FGFR3 construct in vitro
Western blot analysis of DF-1 cells infected with RCAS-dnFGFR3 using anti-myc antibody
showed the presence of an intact protein product of approximately 82kDa (Supplemental Fig.
2A). Antibody staining showed the expression of myc-tagged protein in greater than 80% of
the DF-1 cells infected for 4 days with RCAS-dnFGFR3 (data not shown).
To assess the efficiency of dnFGFR3 in blocking signal transduction, its ability to inhibit the
mitogenic response of DF-1 cells to FGF2 was examined. FGF2 induced increases in the
number of cells in cultures of uninfected cells and cells infected with control virus
(Supplemental Fig. 2C). In cultures infected with RCAS-dnFGFR3, FGF2 treatment resulted
in a markedly reduced mitogenic response (Supplemental Fig. 2C) indicating that this construct
acts as a dominant-negative receptor.
dnFGFR3 affected mandibular morphogenesis
To assess the effects of blocking FGFR3 signaling on mandibular morphogenesis, RCAS-
dnFGFR3 or control viruses were injected into the right half of the mandible of chick embryos
at early (between HH15−20) and later (HH 26) stages of development.
We first examined the onset and the extent of viral infection and the expression of dnFGFR3
in the developing mandible. In embryos injected at early stages of development, expression of
viral Gag and myc-tagged dnFGFR3 was detected in the injected side in a high percentage of
the cells at one day and in the majority of cells at two days (Fig. 3B). At one and two days
post-injection, Gag expression was detected at higher levels and in a higher percentage of cells
including the chondrogenic mesenchyme as compared to myc-tagged dnFGFR3 (data not
shown). At 4 days, Gag and dnFGFR3 were expressed in the mandibular epithelium and most
of the mandibular mesenchyme including the chondrocytes of Meckel's cartilage, osteogenic
condensations and muscles of the tongue (Supplementary Figs. 3A-C and data not shown). At
4 days after injection at later stages of development, expression of Gag and myc-tagged
dnFGFR3 were detected in most of the undifferentiated mandibular mesenchyme, small
clusters of chondrocytes in Meckel's cartilage, and the majority (but not all) of the osteoblasts
in the mandibular bones in the injected side (data not shown). Thus, injections at early stages
resulted in widespread infection throughout the injected side of mandible, whereas injection
at later stages resulted in more localized and limited infections.
Next we examined the effects of dnFGFR3 during mandibular morphogenesis. We have
recently reported that injection of dnFGFR3 resulted in stage and region specific abnormalities
in the outgrowth of the developing mandible, morphogenesis of the Meckel's cartilage and
mandibular bones (Mina et al., 2007). Injection between HH17−20 led to severe defects in
mandibular outgrowth (Figs. 1B & 2A), a high frequency of truncation of the rostral end and
shortening of Meckel's cartilage (83%, n=6, Fig 1B), and high frequency of absence of five of
the mandibular bones (Fig. 1B & Table 1). We also noted alterations in the position and shape
of the elements in the articulating end of the Meckel's cartilage on the injected side (Fig. 1B).
Injections of either RCAS-dnFGFR3 or control viruses at HH15 resulted in a low survival rate.
Surviving embryos injected with RCAS-dnFGFR3 displayed defects in mandibular outgrowth
similar to those after injection at HH17−20 (data not shown). Injection at later stages did not
affect the morphogenesis of Meckel's cartilage (Fig. 1C), caused only mild defects in
mandibular outgrowth in a small percentage of embryos (Mina et al., 2007), and led to the
formation of five smaller than normal mandibular bones (Figs. 1C, D and Table 1). Mandibular
morphogenesis on the injected side of the embryos injected with control viruses (n=24) was
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indistinguishable from the uninjected side (Fig. 1A), indicating that virus injection itself does
not disturb mandibular morphogenesis.
As injections of RCAS-dnFGFR3 between HH17−20 had high survival rates and displayed
the most consistent and severe abnormalities in the outgrowth of the mandibular process and
Meckel's cartilage, further characterization of the underlying mechanisms leading to these
abnormalities in Meckel's cartilage was investigated in this group.
dnFGFR3 did not affect the early patterning of the developing mandible
The earliest detectable defects in the growth of the mandibular processes after injection at early
stages were noted three days after injections (Fig. 2B), suggesting that defects are related to
alterations in expression of components of signaling pathways regulating mandibular
outgrowth.
To investigate this possibility we examined the expression of a selected number of transcription
factors known to be downstream of signaling pathways regulating mandibular patterning.
However, whole mount in situ hybridization revealed no noticeable changes in the intensity
and domain of expression of these transcription factors on the injected sides compared to the
uninjected sides at 2 and 3 days after injections (Figs. 2D-G and data not shown). These results
show that defects in mandibular outgrowth are not related to compromised integrity of the NCC
population in the mandibular mesenchyme, nor to alterations in early signaling activities
regulating mandibular outgrowth.
dnFGFR3 affected cell survival, proliferation and differentiation during chondrogenesis of
Meckel's cartilage
The unchanged patterns of expression of regulatory genes in the treated side suggested that the
truncation of the developing mandible may be related to the abnormality in Meckel's cartilage
that in turn regulates mandibular outgrowth. Thus, we next studied the effects of dnFGFR3 on
the formation and morphogenesis of Meckel's cartilage by examining the patterns of expression
of markers of early (Sox9) and late (Aggrecan) stages of chondrogenesis, and changes in
apoptosis and cell proliferation in the injected and uninjected sides.
At two days after injection, at the time of the formation of chondrogenic condensations, there
were noticeable decreases in the domain and intensity of expression of Sox9 on the injected
sides (Figs. 3A & 3B), indicating that dnFGFR3 led to the formation of a smaller chondrogenic
condensation. Analysis of cell proliferation showed no differences in the number and
distribution of proliferating cells in the mandibular mesenchyme in the injected and uninjected
sides (Table 2). In contrast, TUNEL analysis showed a two fold increase in the number of
apoptotic cells in the mesenchyme on the injected side (Table 2). Apoptotic cells were detected
in the area of the chondrogenic condensation (Fig. 4A) suggesting that the formation of smaller
Sox9-expressing chondrogenic condensation was related to increased apoptosis.
Analysis at three days after injection (after the onset of chondrogenesis and during the
elongation of Meckel's cartilage) showed marked region-specific changes in expression of
Sox9 and aggrecan along the caudal-rostral axis of Meckel's cartilage on the injected side (Figs.
3C-M). The middle and rostral/growing ends of the newly formed Meckel's cartilage on the
injected side showed noticeable changes in the domain and intensity of Sox9 and aggrecan
expression (Figs. 3H-M). On the other hand, the patterns of aggrecan and Sox9 expression in
the caudal region were indistinguishable from the uninjected side (Figs. 3E-G). Comparable
expression of Gag at the different levels along the rostralcaudal axis (Figs. 3G, 3J, 3M)
indicated that the lack of abnormalities in cartilage differentiation in the caudal region is related
to a more advanced stage of differentiation of cartilage at the time of peak infection. In the
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middle region, the decrease in the domain of aggrecan expression (Fig. 3H) was more
noticeable than Sox9 (Fig. 3I) indicating the negative effects of dnFGFR3 on differentiation
of Sox9-expressing cells. Rostral/growing ends of Meckel's cartilage on the injected side
showed decreases in the intensity and domain of Sox9 expression and a lack of aggrecan
expression (Figs. 3K-M) showing the negative effects of dnFGFR3 on differentiation of
Sox9-expressing cells in the growing end, leading to the formation of truncated/shortened
Meckel's cartilage (Fig. 1B). Analysis of cell proliferation and apoptosis showed a 50%
decrease in the number of proliferative cells and a greater than four fold increase in the number
of apoptotic cells in the newly formed Meckel's cartilage in the injected sides (Table 2, Fig.
4B), revealing the roles of FGF/FGFR3 on proliferation and survival of the chondroblasts in
Meckel's cartilage.
The roles of FGF/FGFR3 on the proliferation of chondroblasts and the elongation of Meckel's
cartilage were further supported by decreases in the number of proliferative chondroblasts in
the rostral/growing end of the Meckel's cartilage on the injected side four days after injection.
The rostral region of Meckel's cartilage on the uninjected side contained a significantly greater
number (55%) of proliferative chondroblasts compared to the middle and caudal regions (Table
2). In contrast, the number of proliferative chondroblasts in the rostral end of the Meckel's
cartilage on the injected side was comparable to those in the middle and caudal regions and
decreased as compared to the uninjected side (Table 2). Apoptotic cells were not detected in
Meckel's cartilage in either the injected or uninjected sides (Table 2). However, there was a
greater than three fold increase in the number of apoptotic cells in the mesenchyme rostral to
the growing end of Meckel's cartilage on the injected sides (196.6 ± 10.9) compared to the
uninjected side (58.9 ± 13.3).
Together these observations show roles for FGF/FGFR3 signaling in proliferation, survival
and overt differentiation of Sox9-expressing chondro-progenitors and chondroblasts in
Meckel's cartilage.
dnFGFR3 affected in vitro chondrogenesis
The role of FGF/FGFR3 signaling in chondrogenesis by the mandibular mesenchyme was
further examined in high-density micromass cultures derived from HH23 mandibular
mesenchyme. This culture system allows the formation of chondrogenic condensations and
differentiation, and is a useful tool for examining the roles of signaling pathways during various
stages of chondrogenesis.
Immunohistochemical analysis showed Gag and dnFGFR3 positive cells within cartilaginous
nodules and in the inter-nodular regions (Supplemental Figs. 3E, 3F). Infection with RCAS-
dnFGFR3 resulted in reduced chondrogenesis as demonstrated by significant decreases in the
area and the amount of Alcian blue-stained matrix (Figs. 4G, 4H and Table 3). The decreases
in chondrogenic differentiation were not related to decreases in the size of cultures, as the total
area of micromass cultures was comparable among cultures infected with control virus and
RCAS-dnFGFR3 (Figs. 4G and 4H). Infection with control virus did not affect chondrogenesis
of mandibular mesenchyme as compared to uninfected cultures (data not shown). The reduced
chondrogenesis in high density cultures derived from mandibular mesenchyme infected with
dnFGFR3 is consistent with impaired chondrogenesis in micromass cultures from Fgfr3−/−
limb buds (Davidson et al., 2005).
The effects of dnFGFR3 on chondrogenic condensation in vitro was examined by staining with
PNA, a lectin that selectively binds a cell surface marker(s) on condensing mesenchyme
(Zimmermann and Thies, 1984). Cultures infected with RCAS-dnFGFR3 showed decreases
in the number, but not the size of PNA-positive chondrogenic condensations compared to
cultures infected with control RCAS (Table 3). Morphometric analysis of cartilage nodules in
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cultures stained with both PNA and Alcian blue showed increases in the ratio of PNA to Alcian
blue staining in cultures infected with dnFGFR3 compared to control virus (Table 3), showing
the negative effects of dnFGFR3 on differentiation of the PNA-positive cells at the periphery
of the micromass cultures. In cultures infected with control virus, nearly the entire area of the
cartilage nodules stained with Alcian blue, whereas in cultures infected with RCAS-dnFGFR3,
Alcian blue-stained cartilage nodules were surrounded by PNA-positive cells on the periphery
(not shown).
dnFGFR3 affects osteogenic condensations and appositional growth of mandibular bones
Skeletal staining at HH37 showed that all embryos injected with RCAS-dnFGFR3 displayed
abnormalities in five of the mandibular bones on the injected sides (Table 1 and Figs. 1B, C,
D). Injections at early stages led to absence of bones (articular, angular, supra-angular, dentary
and splenial, Table 1 and Fig. 1B) whereas injection at HH26 led to the formation of smaller
bones in the caudal region (articular, angular, supra-angular) and absence of the bones in the
rostral region (dentary and splenial bones, Table 1 and Figs. 1C, 1D). These abnormalities are
consistent with the patterns of expression of Fgfr3 in the developing mandibular bones.
Fgfr3 is initially expressed in osteogenic condensations and later in the osteoblasts and
periosteal tissues expressing PTH-1R (Supplemental Fig. 1).
The difference in the effects of RCAS-dnFGFR3 in the caudal vs. more rostral bones after
injection at later stages is related to the stage of differentiation of different mandibular bones
along the caudal-rostral axis of the mandible at the time of peak infection (Mina et al., 2007).
The lack of abnormalities in the mento-mandibular bone after injection of dnFGFR3 at all
stages (Figs. 1B-D, Table 1) suggest that development of the mento-mandibular bone is not
dependent on FGF/FGFR3 signaling and is dependent on other signaling pathways, such as
the ET-1-dHAND-Msx1 and BMP/Alk2 signaling pathways shown to play critical roles in the
morphogenesis of the medial/rostral region of the mandible (Dudas et al., 2004; Fukuhara et
al., 2004; Thomas et al., 1998).
To exclude the possibility that the abnormalities in the mandibular bones were related to severe
defects in the outgrowth of the mandibular process and Meckel's cartilage, RCAS-dnFGFR3
was injected into the right maxillary process at early stages (n=8). This treatment did not affect
the outgrowth of the maxillary process but led to the absence of bones derived from the
maxillary process (maxillary bone, palatal process and jugal bone, Figs. 1E, F).
Next we examined the patterns of expression of early (PTH-1R and Runx2) and late
(Osteocalcin, OC) markers of osteoblast differentiation, as well as changes in apoptosis and
proliferation in angular and supra-angular bones, as these bones were easily identifiable in
cross sections and were consistently affected after both early and late injections (Table 1).
Four days after injection at early stages, the region corresponding to the osteogenic
condensations giving rise to the supra-angular and angular bones on the injected side showed
a lack of expression of both PTH-1R and Runx2 (Fig. 5B and data not shown), a 51% decrease
in the number of proliferative cells, and an approximately 78% increase in the number of
apoptotic cells (Table 2). These changes, together with the lack of histological evidence for
osteogenic condensation in Hematoxylin and Eosin stained sections (Fig. 5A) revealed the
essential roles of FGF/FGFR3 on proliferation and survival of osteo-progenitor cells in
osteogenic condensations.
Analyses of the angular bone six days after late injection at HH26 showed significant reductions
in the domains of expression of PTH-1R, Runx2 and OC, a 24% decrease in the number of
proliferating cells, and a 70% increase in apoptosis compared to the uninjected side (Table 2
and Figs. 5C-K). Osteoblasts on the injected side expressed PTH-1R and OC, but low or no
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detectable Runx2 (Figs. 5C-K). These results showed that FGF/FGFR3 is essential for
proliferation and survival of osteoblasts and the osteoprogenitors in the periosteum.
Effects of dominant negative FGFR2 on the formation of Meckel's cartilage and mandibular
osteogenesis
The patterns of expression of Fgfr2 in the developing chick mandibular skeleton are similar to
Fgfr3 (Supplemental Fig. 1), suggesting the possibility of redundant and/or cooperative roles
for FGFR2c and FGFR3c in the chondrogenesis and osteogenesis of the mandibular
mesenchyme. The role of FGFR2c-mediated signaling in the formation and elongation of
Meckel's cartilage and mandibular osteogenesis was examined using a previously characterized
RCAS-dnFGFR2 shown to decrease proliferation in primary osteoblast cultures (Ratisoontorn
et al., 2003).
Skeletal staining after early injection of RCAS-dnFGFR2 (n=32) revealed the formation of
slightly smaller articular, angular, supra-angular, and splenial bones on the injected side of
90% of the embryos (Fig. 1G, Table 1). The formation of smaller mandibular bones on the
injected sides in our study is consistent with roles of FGF/FGFR2c in osteoblast proliferation
and differentiation (Eswarakumar et al., 2002;Yu et al., 2003). Mice lacking the Fgfr2c isoform
(Eswarakumar et al., 2002) and conditional inactivation of Fgfr2 in the osteogenic lineage
(Yu et al., 2003) showed delayed onset of osteoblast differentiation with decreases in Runx2
expression (Eswarakumar et al., 2002).
However, there were no severe abnormalities in the outgrowth of the mandibular processes or
morphogenesis of Meckel's cartilage on the injected side (Fig. 1G). Furthermore, RCAS-
dnFGFR2 had no discernable effect on in vitro chondrogenesis of mandibular mesenchyme
(Table 3). The lack of noticeable abnormalities on in vivo and in vitro chondrogenesis of
mandibular mesenchyme by dnFGFR2 was not related to unsuccessful infection or inability
of dnFGFR2 to act as a dominant negative receptor. Western blot analysis of DF-1 cells infected
with RCAS-dnFGFR2 showed the presence of an intact protein product of approximately
82kDa (Supplemental Fig. 2B). Immunohistochemical analysis showed widespread expression
of Gag and HA-tagged dnFGFR2 in the injected side of mandibles and in infected micromass
cultures (Supplemental Figs. 3D, G, H, and data not shown). RCAS-dnFGFR2 also resulted
in a markedly reduced mitogenic response to FGF2 (Supplemental Fig. 2C). Furthermore,
injection of RCAS-dnFGFR2 in the developing forelimb at HH19−20 (n=7) led to shortening
of the entire limb and various skeletal elements (Fig. 1H). Skeletal preparations at HH37
showed shortened ossified regions in the humerus (4/7), radius (5/7) and ulna (3/7) in the
injected limbs. Other abnormalities included a lack of osteogenesis in the proximal phalanges
and truncations of the cartilaginous middle and distal phalanges (7/7) (Fig. 1H). These changes
in the developing limb are consistent with the abnormalities in mice lacking FGFR2c
(Eswarakumar et al., 2002;Yu et al., 2003).
Discussion
Our expression data together with our analysis of the effects of blocking FGFR3 and FGFR2
signaling on mandibular skeletogenesis provide new evidence for essential roles of FGF/
FGFR3 signaling in the formation of osteogenic condensations, and in the morphogenesis and
elongation of Meckel's cartilage. Our study also shows that appositional growth of mandibular
bones is dependent on both FGFR2 and FGFR3 signaling.
Roles for FGF signaling during morphogenesis and elongation of Meckel's cartilage
Our observations show that blocking FGFR3 signaling in the developing chick mandible
between HH17−20 did not affect the initial formation of Meckel's cartilage but affected further
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morphogenesis and the elongation of Meckel's cartilage. Blocking FGFR3 signaling affected
the proliferation, survival and differentiation of cells within the chondrogenic mesenchyme
and chondroblasts. This provides new evidence for the essential roles of FGF/FGFR3 signaling
during the morphogenesis and elongation of Meckel's cartilage.
We have shown that blocking FGFR3 signaling during the formation of Meckel's cartilage led
to the truncation of the rostral/growing end of the Meckel's cartilage. The effects were mediated
by decreased proliferation of chondroblasts in Meckel's cartilage and impaired differentiation
of Sox9 expressing chondrogenic cells. The essential role of FGFR3 signaling on proliferation
of chondrogenic cells in Meckel's cartilage in chick embryos provides support for mitogenic
effects of FGFR3 signaling on chondroblasts/chondrocytes during embryonic development.
The positive roles of FGFR3 mediated signaling on chondrocyte proliferation and
differentiation are different from the negative roles of FGFR3 on chondrocytes during the
postnatal stages of development (Colvin et al., 1996; Deng et al., 1996; Eswarakumar and
Schlessinger, 2007). Although a comprehensive analysis of craniofacial defects in Fgfr3−/−
and Fgfr3c−/− mice during embryonic development has not been reported, a lack of defects in
the developing mandible and Meckel's cartilage in these transgenic mice may not be surprising
as the main body of the Meckel's cartilage in mammals is a transient structure (Harada and
Ishizeki, 1998). The permanent fate of Meckel's cartilage in birds as compared to its transient
fate in mammals allowed us to gain insight into roles of FGF/FGFR3 in morphogenesis of
Meckel's cartilage. The positive roles of FGFR3 signaling on proliferation of chondroblasts
during early embryonic development in our study are also supported by findings in transgenic
mice carrying an activating mutation in FGFR3 (Iwata et al., 2000; Iwata et al., 2001). These
animals displayed increases in the proliferation of chondroblasts in the growth plate at E15.5
(Iwata et al., 2000; Iwata et al., 2001) and overgrowth of other hyaline cartilages, including
the trachea and nasal septum (Iwata et al., 2001).
Our observations also show essential roles of FGF/FGFR3 signaling in the survival and
differentiation of Sox9-expressing chondrogenic cells. Sox9 is a transcription factor that is
expressed in chondrogenic mesenchyme with critical roles in the overt differentiation of
chondrocytes and their survival and proliferation (Lefebvre et al., 1998). Inactivation of
Sox9 in limb buds prior to the formation of chondrogenic condensations led to an absence of
cartilage elements (Akiyama et al., 2002). Inactivation of Sox9 in condensed mesenchymal
cells and differentiated chondrocytes revealed the essential roles of Sox9 in proliferation,
survival and overt differentiation of chondroblasts (Akiyama et al., 2002). The truncation of
Meckel's cartilage and the hypoplastic mandibular processes on the injected side in our study
suggest that the effects of FGFR3 signaling on Meckel's cartilage are mediated at least in part
through Sox9. This is further supported by the similarities in the changes observed in our study
and those reported in Sox9−/+ mutant mice (Bi et al., 2001),
The overlapping expression patterns of FGFR2c and FGFR3c in the chondrogenic
condensation and the newly formed Meckel's cartilage suggest the possibility of cooperative/
redundant roles of these receptors in the morphogenesis of Meckel's cartilage. However, our
study shows that despite wide expression, dnFGFR2 did not affect chondrogenesis and
elongation of Meckel's cartilage in vivo or in vitro, suggesting dispensable/unessential roles of
FGFR2 signaling in this process. Since the peak expression of dnFGFR2 and dnFGFR3 occurs
during the formation of the chondrogenic condensation, the roles of signaling through these
receptors during early stages of mandibular morphogenesis remains unknown.
Roles for FGF signaling during osteogenesis of the mandibular bones
The importance of FGFRs in osteogenesis has been highlighted by the discoveries that gain-
of-function point mutations within the amino acid coding sequences of FGFRs1−3 are
responsible for craniosynostoses syndromes, characterized by premature fusion of cranial
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sutures due to dysregulated intramembranous bone formation (Ornitz and Marie, 2002).
FGFR1 stimulates osteoblast differentiation (Hajihosseini et al., 2004; Iseki et al., 1999; Zhou
et al., 2000). FGFR2 is involved in regulating osteoblast proliferation and differentiation
(reviewed by Eswarakumar et al., 2005; Ornitz and Marie, 2002). The formation of mandibular
bones with reduced size after injection of dnFGFR2 is consistent with essential roles of FGF/
FGFR2 signaling in osteoblast proliferation and differentiation.
Moreover, our results provide new evidence for the essential roles FGF/FGFR3 signaling in
the survival, proliferation and differentiation of osteoprogenitors within the osteogenic
condensations and periosteum of the chick mandibular bones. We show that blocking FGFR3
signaling at early stages of mandibular development resulted in decreased cell survival and
proliferation and a complete absence of osteogenic mesenchyme. We also show that blocking
FGFR3 signaling at later stages of mandibular development after the formation of osteogenic
mesenchyme resulted in smaller bones through its effects on survival and proliferation of
osteoblasts and osteoprogenitor cells within the periosteum, which is responsible for
appositional growth of the mandibular bones.
The roles of FGFR3 signaling in mandibular osteogenesis support the recent observations in
several transgenic mouse models (Ornitz, 2005; Ornitz and Marie, 2002). Transgenic mice
carrying an activating (G375C) mutation in FGFR3 displayed increased expression of markers
of osteoblast differentiation and advanced ossification in the long bones (Chen et al., 1999).
Inhibition of FGFR3 expression by Twist inhibited the differentiation of osteoprogenitor cells
into osteoblasts (Funato et al., 2001). More recently it has been shown that young adult Fgfr3
−/− and Fgfr3c−/− mice were osteopenic and displayed decreased thickness of cortical and
trabecular bones (Valverde-Franco et al., 2004, Eswarakumar and Schlessinger, 2007). In the
long bones, cortical bone in the diaphyses is formed by direct differentiation of osteoprogenitor
cells in the periosteum into osteoblasts, a process that is similar to intramembranous
ossification, providing additional support for essential roles for FGF/FGFR3 signaling in
intramembranous ossification. Interestingly, FGFR3 is detected in sutural osteogenic fronts
(Rice et al., 2000; Rice et al., 2003), and Saethre-Chotzen syndrome associated
craniosynostosis is caused by mutations in the gene encoding TWIST or FGFR3 (Chun et al.,
2002).
The change in the expression of Runx2 in our study suggests that the effects of FGF signaling
in osteoblasts are mediated through Runx2. Runx2 is expressed in osteogenic condensations
and acts as an osteoblast differentiation factor (reviewed by Stein et al., 2004). Runx2 is also
expressed in terminally differentiated osteoblasts, where it directly stimulates transcription of
osteoblast-related genes (reviewed by Franceschi and Xiao, 2003; Stein et al., 2004). Runx2
expression and functional activity are controlled by the mitogen-activated protein kinase
(MAPK) pathway activated by a variety of signals, including those initiated by FGFs
(Franceschi and Xiao, 2003).
However, it is possible that the effects of dnFGFR3 on mandibular osteogenesis may be indirect
and mediated by regulating angiogenesis. Fgfr3−/− mice showed a down-regulation of vascular
endothelial growth factor (VEGF) (Amizuka et al., 2004), whereas transgenic mice carrying
an activating mutation in FGFR3 (G380R) displayed premature and increased vascularization
(Cormier et al., 2002; Segev et al., 2000).
Potential FGF ligands involved in mandibular skeletogenesis
Our observations reveal essential roles of FGFs capable of binding with high affinity to FGFR3
in the morphogenesis of avian Meckel's cartilage and mandibular bones. Binding studies have
shown that FGFR3b and FGFR3c isoforms are both activated by FGF1 and by FGF9 (Ornitz
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et al., 1996; Zhang et al., 2006). In addition, FGFs 2, 4, 6, 8 and 18 also bind with high affinity
to FGFR3c (Ornitz et al., 1996; Zhang et al., 2006).
A growing body of evidence indicates that among these ligands, FGF18 is the most likely
physiological ligand for FGFR3 in both osteogenesis and chondrogenesis (Davidson et al.,
2005; Ellsworth et al., 2002; Liu et al., 2007; Liu et al., 2002; Ohbayashi et al., 2002; Reinhold
et al., 2004). In vitro studies have shown that FGF18 can bind to and interact strongly with
FGFR3c, moderately with FGFR2c, but not with FGFR1c (Zhang et al., 2006). Analysis of
abnormalities in mice lacking Fgf18 at different developmental stages has provided evidence
for both positive and negative roles of FGF18/FGFR3 signaling on chondrocyte proliferation
during early and later stages of development respectively (Liu et al., 2007; Liu et al., 2002;
Ohbayashi et al., 2002). The hypoplastic mandible and shortened Meckel's cartilage in Fgf18
−/− mice (Liu et al., 2007), together with expression of Fgf18 in the chondrogenic mesenchyme
and perichondrium of Meckel's cartilage in human fetuses (Cormier et al., 2005), provide
support for roles of FGF18/FGFR3 signaling in the morphogenesis and elongation of Meckel's
cartilage.
Fgf18−/− mice also displayed delayed ossification in the skeletal elements formed by both
endochondral and intramembranous ossification (Liu et al., 2007; Liu et al., 2002; Ohbayashi
et al., 2002). Young adult Fgf18−/− mice, similar to Fgfr3−/− mice (Amizuka et al., 2004),
were dwarfed, showed decreased expression of VEGF, Runx2, osteopontin, and osteocalcin
suggesting that the roles of FGF18/FGFR3 in osteogenesis, including intramembranous
ossification of chick mandible in our study, are indirect.
Specificity of dnFGFR Approach
In a complex system such as the developing mandible with overlapping patterns of expression
of Fgfrs, one possible explanation of our findings is that the abnormalities caused by dnFGFR3
are the result of a general dominant-negative effect by sequestering various FGFs and/or by
inhibition of signaling through other FGFRs. This possibility is difficult to reconcile with our
data as dnFGFR2 led to a markedly milder phenotype, and there were no changes in the
morphogenesis of the tongue and mandibular muscles, shown to be dependent on signaling
through FGFR1 and FGFR4 (Flanagan-Steet et al., 2000; Marics et al., 2002). The milder
phenotype caused by dnFGFR2 may be caused by heterodimerization of dnFGFR2 with
FGFR3c.
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Figure 1. Effects of over-expression of dnFGFR3 and dnFGFR2 on skeletal development
(A-D) Whole-mount skeletal preparation of mandibles at HH37 after injection of control virus
(A), or RCAS-dnFGFR3 (B-D) into the right mandibular process at HH17/18 (B) or HH26 (C,
D). In all pictures, the injected side is on the left.
(A) A mandible injected with control virus at HH17/18, showing that skeletogenesis on the
injected side of the mandible is indistinguishable from the uninjected side. (B) A mandible
injected with dnFGFR3 at HH17/18 showing severe truncation of Meckel's cartilage, absence
of five mandibular bones and the formation of a smaller mentomandibular bone (Me) on the
injected side. Also note the alterations in the position and shape of the elements in the
articulating end of the Meckel's cartilage on the injected side. (C) A mandible injected with
dnFGFR3 at HH26 showing the absence of the angular, splenial, and dentary bones and the
formation of smaller articular, supra-angular, and mentomandibular bones. (D) Schematic
drawing illustrating the effects of dnFGFR3 injected at HH26 on the developing bones.
(E) Inferior view of a skeletal preparation of a head at HH37 after injection of RCAS-dnFGFR3
into the maxillary process at HH17/18. The mandible has been removed and the injected side
is on the left of the picture. On the injected side, the maxillary, palatal and jugal bones are
absent. The premaxillary, quadratojugal and pterygoid bones are smaller than those on the
uninjected side. The frontal and nasal bones were unaffected and were lost on the uninjected
side during dissection. (F) Schematic drawing illustrating the effects of the dnFGFR3 on the
upper beak shown in E.
(G) A mandible injected with dnFGFR2 at HH17/18 showing the lack of severe defects in the
developing Meckel's cartilage and smaller articular, angular, supra-angular, and splenial bones.
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(H) Skeletal preparation at HH37 of the forelimb injected with RCAS-dnFGFR2 at HH19−20
(left) and the contra-lateral uninjected limb (right) from the same embryo. Note the shortening
of the injected limb as compared to the uninjected limb. Also note the shortening of the
humerus, radius, ulna, and phalanges, shortened ossified regions stained with Alizarin red of
the humerus (indicated by dashed lines), radius, and ulna, and a lack of ossification in most
phalanges (indicated by arrow) in the injected limb. Scale bars in all pictures=1mm
An=angular, Ar=articular, De=dentary, F=frontal, Hu=humerus, J=jugal, MC=Meckel's
cartilage, Me=mentomandibular, Mx=maxillary, N=nasal bone, Ph=phalanges, Pl=palatal,
Pm=premaxillary, Pt=Pterygoid, Qi=quadratojugal, Ra=radius, Sa= supra-angular, Sp=
splenial, and Ul=ulna.
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Figure 2. Effects of dnFGFR3 on mandibular outgrowth, initial formation of MC and on the
expression of transcription factors in the developing mandible
(A) Inferior view of a chicken head at HH37 injected with RCAS-dnFGFR3 at HH17/18. (B)
Frontal view of a chicken head at HH28−29 injected with RCAS-dnFGFR3 at HH17/18. (C)
Alcian blue preparation of the mandible from the embryo in B. The injected sides of the
mandible are on the left. Note the severe deviation of the mandible (indicated by arrow) towards
the injected side at HH37 (8 days after injection). Also note the detectable deviation in the
midline of the lower jaw from the upper jaw (indicated by dashed lines in B) and the reduced
length of Meckel's cartilage (C) on the injected side. Scale bars=1mm
D-G are frontal views of whole-mount in situ hybridization analysis for Msx1 (D), dHand (E),
Barx1 (F), and Dlx5 (G) in the mandibular processes two days after injection of RCAS-
dnFGFR3 at HH17/18. In all pictures, the injected side of the mandible is on the left. There
are no detectable changes in the domains and levels of expression of these transcription factors
on the injected sides of the mandible compared to the uninjected sides. Scale bars=500 μm
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Figure 3. Effects of dnFGFR3 on the expression of markers of chondrogenesis in Meckel's cartilage
Pseudo colored images of in situ hybridization of Sox9 (A, C, D, F, I, L) and Aggrecan (E, H,
K) and immunohistochemical detection of Gag (B, G, J, M) on sections from the developing
mandible two (A, B) and three (C-M) days after injection of dnFGFR3 into the right half of
the developing mandible at HH17/18. In all pictures the injected side of the mandible is on the
left.
(A) Sagittal section through a mandible two days after injection showing the reductions in the
domain of expression of Sox9 on the injected side. B is a sagittal section incubated with antibody
to Gag showing the extensive expression of Gag in the mesenchyme on the injected side.
(C & D) Sagittal sections through mandibles three days after injection showing the reductions
in the domain of expression of Sox9 on the injected side (C) as compared to the uninjected side
(D).
(E-G) are adjacent cross sections through the caudal region of the mandible showing the
unchanged patterns of expression of Aggrecan (E) and Sox9 (F) in Meckel's cartilage on the
injected sides. The expression of Gag is shown in an adjacent section (G).
(H-J) are adjacent cross sections through the middle region of the mandible showing decreases
in the domains and levels of expression of Aggrecan (F) and Sox9 (G) in Meckel's cartilage in
the injected sides. (J) is an adjacent section processed for immunohistochemistry with Gag
antibody.
K-M are adjacent cross sections through the rostral region of the mandible showing the lack
of expression of Aggrecan (K) and decreases in the domain and level of Sox9 (L) in Meckel's
cartilage on the injected side. M is an adjacent section processed for immunohistochemistry
with Gag antibody. Scale bars in all pictures=100 μm.
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Figure 4. Effects of dnFGFR3 on the distribution of proliferative and apoptotic cells in mandibular
mesenchyme and in vitro chondrogenesis
In all pictures the injected side of the mandible is on the left. (A) is a sagittal section through
a mandible two days after injection of RCAS-dnFGFR3 at HH17/18 processed for TUNEL
staining. Note the increased number of apoptotic cells in the area of the chondrogenic
condensation (indicated by arrows) on the injected side. B is a sagittal section through a
mandible three days after injection of RCAS-dnFGFR3 at HH17/18 processed for
immunohistochemistry with an H3-p antibody. Note the decreased number of proliferative
cells in the newly formed MC (outlined by dashed lines) on the injected side.
(C-F) are adjacent cross sections through the angular bone (outlined by dashed lines) six days
after injection of RCAS-dnFGFR3 at HH26 processed for TUNEL staining (C and D) and
immunohistochemistry with an H3-p antibody (E and F). Note the increases in the number of
apoptotic cells in osteoblasts and periosteum (indicated by arrowhead) on the injected side (C)
as compared to the uninjected side (D). Also note the reduced number of proliferative cells in
the periosteum (indicated by arrows) on the injected side (E) as compared to the uninjected
side (F). Sections B, C, and D were counterstained with Alcian blue to identify Meckel's
cartilage. Scale bars in A-F= 200μm.
(G & H) are micromass cultures infected for four days with control virus (G) or RCAS-
dnFGFR3 (H). Cultures were processed for Alcian blue and hematoxylin staining. Note the
decreases in Alcian blue staining in cultures infected with RCAS-dnFGFR3 (H) compared to
cultures infected with control virus (G). The arrows outline the periphery of the micromass
cultures stained with hematoxylin. Scale bars in G and H=1 mm
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Figure 5. Effects of dnFGFR3 on osteogenic condensations and expression of markers of
osteogenesis in the mandibular bones
In both pictures, the injected side of the mandible is on the left. (A & B) are adjacent cross
sections through the caudal region of the mandibular process at HH31 after injection of RCAS-
dnFGFR3 at HH17/18. Note the absence of morphologically recognizable osteogenic
condensations (outlined by dashed lines) for the supra-angular and angular bones adjacent to
Meckel's cartilage on the injected side of the mandible. (B) Pseudo-colored image of in situ
hybridization showing expression of PTH-1R in the osteogenic condensations of the supra-
angular and angular bones on the uninjected side. PTH-1R is not detected on the injected side.
Scale bars= 200μm.
(C-K) Pseudo-colored images of in situ hybridization for PTH-1R (C, F, G), Runx2 (D, H, I)
and OC (E, J, K) in the angular bone (outlined by dashed lines) in adjacent cross sections
through the caudal region of mandible 6 days after injection of RCAS-dnFGFR3 at HH26. The
injected sides of the mandible are on the left. The domains of expression of PTH-1R (C),
Runx2 (D) and OC (E) in the angular bones on the injected sides of the mandible are smaller
than those on the uninjected sides. Also note the absence of the supra-angular bone on the
injected sides.
Figures F-K are higher magnification images of the angular bone on the injected (F, H, J) and
uninjected (G, I, K) sides. Note the marked reduction in the number of PTH-1R and OC
expressing osteoblasts in the angular bones on the injected sides as compared to the uninjected
sides. Runx2 is expressed in osteoblasts on the uninjected side (I), but not on the injected side
(H). PTH-1R and Runx2 are expressed in the periosteum (indicated by arrows) on the injected
and uninjected sides.An=Angular, MC= Meckel's cartilage, and Sa=Supra-angular. Scale
bars=200μm.
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Table 3
Quantification of the effects dnFGFR3 on in vitro chondrogenesis of mandibular mesenchyme.
Analysis Days RCAS RCAS-dnFGFR3 RCAS-dnFGFR2
# of aggregates 2 134.3 ± 17.3
(n=6)
111 ± 5.5
(n=6)
ND
Size of aggregates (mm2) 2 0.05 ± 0.009
(n=6)
0.045 ± 0.005
(n=6)
ND
Relative absorbance
4 117.9 ± 6.3
(n=16)
73.8 ± 2.0*
(n=12)
105.8 ± 4.5
(n=12)
6 160.0 ± 6.1
(n=16)
88.2 ± 8.7*
(n=12)
146.3 ± 8.2
(n=12)
Relative area stained by Alcian blue
4 8.46 ± 0.33
(n=16)
5.53 ± 0.14*
(n=12)
7.87 ± 0.24
(n=12)
6 10.67 ± 0.27
(n=16)
6.24 ± 0.69*
(n=12)
10.18 ± 0.67
(n=12)
PNA/Alcian blue
3 1.07 + 0.01
(n=13)
1.18 + 0.02*
(n=11)
ND
4 1.12 + 0.02
(n=10)
1.25 + 0.11*
(n=10)
ND
The quantification of various parameters was determined as described in the Materials and Methods. Values represent the mean ± S.E. for 6−12 cultures
(indicated in parenthesis) in two or three independent experiments. ND, not determined. Asterisks indicate statistical significance at p<0.01.
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